Re: Gammie A et al. What are the additional signs and symptoms in patients with detrusor underactivity and coexisting detrusor overactivity?

被引：0

作者：

Schaefer, Werner ^{[1
]}

机构：

[1] 3400 Tanglewood Dr, Sarasota, FL 34239 USA

来源：

NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷 / 08期

关键词：

D O I：

10.1002/nau.23756

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2981 / 2983

页数：3

共 41 条

[21] Re: Diniz-Filho et al.: Fast visual field progression is associated with depressive symptoms in patients with glaucoma Reply
Diniz-Filho, Alberto
Abe, Ricardo Y.
Cho, Hyong Jin
Baig, Saif
Gracitelli, Carolina P. B.
Medeiros, Felipe A.
OPHTHALMOLOGY, 2017, 124 (02) : E21 - E21
[22] Response to Salehi et al. re: ''Analysis of Online Videos on Facial Feminization Surgery: What Are Patients Watching on TikTok and YouTube?''
Moayer, Roxana
Ziltzer, Ryan S.
FACIAL PLASTIC SURGERY & AESTHETIC MEDICINE, 2023, 25 (06) : 531 - 532
[23] Letter to the Editor re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et al.
Volkman, David
BRAIN BEHAVIOR AND IMMUNITY, 2010, 24 (06) : 1027 - 1027
[24] Re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. Eur Urol 2012;61:928-35
Mouracade, Pascal
EUROPEAN UROLOGY, 2012, 61 (05) : E41 - E41
[25] Re: Rourke et al.: Clinical Spectrum of Presenting Signs and Symptoms of Anterior Urethral Stricture: Detailed Analysis of Single-institutional Cohort (Urology 2012; 79:1163-1167)
Goel, Apul
Goel, Anuj
UROLOGY, 2013, 81 (01) : 216 - 216
[26] Re: Goel S et al. Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysis. Urology. 2020. doi:10.1016/j.urology.2020.03.007
Sinha, Sanjay
Matai, Lavina
UROLOGY, 2020, 144 : 275 - 276
[27] Reply to Letter to the Editor by D. Volkman re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et al.
Alaedini, Armin
BRAIN BEHAVIOR AND IMMUNITY, 2010, 24 (06) : 1028 - 1028
[28] Re: Goel S et al. Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysis. Urology. 2020. doi:10.1016/j.urology.2020.03.007 REPLY
Goel, Shokhi
Pierce, Hudson
Pain, Kevin
Christos, Paul
Dmochowski, Roger
Chughtai, Bilal
UROLOGY, 2020, 144 : 276 - 276
[29] Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al.
Vitetta, Luis
Andersen, Tomas
Quezada, Michelle
Rutolo, Dave
Henson, Jeremy D.
CANNABIS AND CANNABINOID RESEARCH, 2022, 7 (02) : 231 - 233
[30] Reply to Pascal Mouracade's Letter to the Editor re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. Eur Urol 2012;61:928-35
Manecksha, Rustom P.
Cullen, Ivor M.
Ahmad, Sarfraz
McNeill, Graeme
Flynn, Robert
McDermott, Thomas E. D.
Grainger, Ronald
Thornhill, John A.
EUROPEAN UROLOGY, 2012, 61 (05) : E42 - E42

← 1 2 3 4 5 →